Prada-Oliveira, J
Abbreviations GLP-1: Glucagon-like peptide-1 GIP: Gastric inhibitory polypeptide NAFLD: Non-alcoholic fatty liver disease NASH: Non-alcoholic steatohepatitis LDL-C: Low-density lipoprotein cholesterol HDL-C: High-density lipoprotein- cholesterol SPPS: Solid-phase peptide synthesis PFR: Plug-flow reactor DMSO: Dimethyl sulfoxide HPLC: High-performance liquid chromatography EGP: Endogenous Glucose Production MPTP: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 6- OHDA: 6-Hydroxydopamine RCTs: Randomized clinical Trials ROS: Reactive oxygen species CSVD: Cerebral small vessel disease FFAs: Free fatty acids References American Diabetes Association
L-carnitine transports fatty acids into mitochondria, supporting cellular energy production to help combat chronic fatigue
Frat Tutal Bariatrik Cerrahi Uzman | Nisan 2026 | Obezite tedavisinde yeni bir dnem balyor
Which medications should be discontinued or adjusted when titrating Mounjaro (tirzepatide)?
Unlike older GLP-1 medications that target only one hormone, tirzepatide is the first dual GLP-1 (glucagon-like peptide 1) and GIP receptor agonist that offers greater benefits, including stronger appetite suppression, deeper metabolic changes, and more significant weight loss